Pharmacoepidemiology and Drug Safety Open Access Journals
20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • RefSeek
  • Hamdard University
  • SWB online catalog
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Recommended Webinars & Conferences
Journal Flyer
Flyer image

Editorial Board

Richard L Slaughter
Professor, Department of Pharmacy Practise
Wayne State University, USA

Victor P Andreev, PhD
Executive Editor
Associate Professor, Department of Psychiatry and Behavioral Sciences

Dr. Amgad M. Rabie, PhD
Executive Editor
Professor & Researcher of Medicinal Chemistry & Drug Discovery
Mansoura University, Egypt

Submit Manuscript

Submit manuscript at or send as an e-mail attachment to the Editorial Office at [email protected]

About the Journal

NLM ID: 101607843
Index Copernicus Value: 82.47

• Advances in Pharmacoepidemiology and Drug Safety is a peer-reviewed open access journal focusing on studies pertaining to rare adverse drug reactions, drug efficacy evaluations, drug interaction quantifications, patterns of drug usage, herbal medicines, randomized control trials, case control studies, cross-sectional studies, case cross over studies and cohort studies.

• The journal also serves as a compendium of knowledge in pharmacoepidemiology and drug safety which can be readily accessed by physicians, surgeons, medical scientists, public health professionals, medical students, clinicians, lab researchers, academicians and industry for keeping themselves updated and also to formulate further research programs.

• The journal regularly publishes reports covering wide range of topics which include new challenges of over drug use, insufficient use and inappropriate use of drugs; Pharmacoepidemiology; improvements in molecular biology techniques and identification of the genetic determinants of drug effects.

Fast Editorial Execution and Review Process (FEE-Review Process):
Advances in Pharmacoepidemiology and Drug Safety is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.


Articles published in Advances in Pharmacoepidemiology and Drug Safety have been cited by esteemed scholars and scientists all around the world. Advances in Pharmacoepidemiology and Drug Safety has got h-index 13 , which means every article in Advances in Pharmacoepidemiology and Drug Safety has got 13 average citations.

Journal Highlights

Current Issue Highlights